Comparison of CT/GC diagnosed
| Q1 2010* | Q1 2011* | |
| MSM attendances | 4063 | 3975 |
| MSM diagnosed | 166 | 354 |
| Diagnoses of CT or GC | 199 | 494 |
| CT (total) | 81 | 225 |
| CT Urethra | 43 | 69 |
| CT Pharynx | 0 | 32 |
| CT Rectum | 25 | 113 |
| LGV | 13 | 11 |
| GC (total) | 118 | 269 |
| GC Urethra | 58 | 45 |
| GC Pharynx | 11 | 121 |
| GC Rectum | 49 | 103 |
| MSM with infection at | ||
| 1-site | 146 (88%) | 258 (72.9%) |
| 2-site | 19 (11.4%) | 80 (22.6%) |
| 3-site | 1 (0.6%) | 16 (4.5%) |
| Diagnoses due to triple NAAT testing protocol (% of total): | 322 | |
| Pharyngeal CT | 32 (100%) | |
| Rectal CT | 106 (93.8%) | |
| Pharyngeal GC | 109 (90.1%) | |
| Rectal GC | 75 (72.8%) | |
| Diagnoses treated due to triple-site NAAT testing (% of total) | 234 | |
| Pharyngeal CT | 20 (62.5%) | |
| Rectal CT | 78 (69%) | |
| Pharyngeal GC | 76 (62.8%) | |
| Rectal GC | 60 (58.3%) | |
↵* Q1 1st January to 1st April.